Pubblicazioni

Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysis

2024 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Laborante, Renzo; Occhipinti, Giovanni; Zito, Andea; Spadafora, Luigi; Biondi-Zoccai, Giuseppe; Nerla, Roberto; Castriota, Fausto; D'Amario, Domenico; Capodanno, Davide; Jeong, Young-Hoon; Kimura, Takeshi; Mehran, Roxana; Angiolillo, Dominick J

Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis

2024 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Occhipinti, Giovanni; Benenati, Stefano; Laborante, Renzo; Ortega-Paz, Luis; Franchi, Francesco; D'Amario, Domenico; Nerla, Roberto; Castriota, Fausto; Frati, Giacomo; Biondi-Zoccai, Giuseppe; Sciarretta, Sebastiano; J Angiolillo, Dominick

Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study

2024 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia

P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis

2024 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Laudani, Claudio; Occhipinti, Giovanni; Spagnolo, Marco; Gragnano, Felice; D'Amario, Domenico; Pio Navarese, Eliano; Mehran, Roxana; Valgimigli, Marco; Capodanno, Davide; J Angiolillo, Dominick

Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome

2023 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Gargiulo, Giuseppe; Benenati, Stefano; Mehran, Roxana; J Angiolillo, Dominick

Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19. A systematic review and meta-analysis of randomized controlled trials

2022 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Ortega-Paz, Luis; Galli, Mattia; Capodanno, Davide; Franchi, Francesco; Rollini, Fabiana; Bikdeli, Behnood; Mehran, Roxana; Montalescot, Gilles; Michael Gibson, C; D Lopes, Renato; Andreotti, Felicita; J Angiolillo, Dominick

Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin. A pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy

2022 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Franchi, Francesco; Rollini, Fabiana; Been, Latonya; Abou Jaoude, Patrick; Rivas, Andrea; Zhou, Xuan; Jia, Sida; Maaliki, Naji; Hoon Lee, Chang; M Pineda, Andres; Suryadevara, Siva; Soffer, Daniel; M Zenni, Martin; Geisler, Tobias; K Jennings, Lisa; A Bass, Theodore; J Angiolillo, Dominick

Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19

2022 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Ortega-Paz, Luis; Galli, Mattia; Angiolillo, Dominick J.

Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis

2022 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Ameri, Pietro; De Marzo, Vincenzo; Zoccai, Giuseppe Biondi; Tricarico, Lucia; Correale, Michele; Brunetti, Natale Daniele; Canepa, Marco; De Ferrari, Gaetano Maria; Castagno, Davide; Porto, Italo

Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials

2022 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Capodanno, Davide; Benenati, Stefano; D'Amario, Domenico; Crea, Filippo; Andreotti, Felicita; J Angiolillo, Dominick

Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a network metanalysis on 605,771 patients

2021 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Menichelli, Danilo; Del Sole, Francesco; Di Rocco, Arianna; Farcomeni, Alessio; Vestri, Anna Rita; Violi, Francesco; Pignatelli, Pasquale; Yh Lip, Gregory; Pastori, Daniele

Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

2021 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Mancusi, Costantino; de Simone, Giovanni; Hitij, Jana Brguljan; Sudano, Isabella; Mahfoud, Felix; Parati, Gianfranco; Kahan, Thomas; Barbato, Emanuele; Pierard, Luc A; Garbi, Madalina; Flachskampf, Frank A; Gerdts, Eva

Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk. the FORWARD study

2021 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Desideri, Giovambattista; Rajzer, Marek; Gerritsen, Martijn; Nurmohamed, Michael T; Giannattasio, Cristina; Tausche, Anne-Kathrin; Borghi, Claudio

Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials

2021 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Benenati, Stefano; Galli, Mattia; De Marzo, Vincenzo; Pescetelli, Fabio; Toma, Matteo; Andreotti, Felicita; Della Bona, Roberta; Canepa, Marco; Ameri, Pietro; Crea, Filippo; Porto, Italo

Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns

2021 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Princi, Giuseppe; Crea, Filippo; D'Amario, Domenico

Omega-3 fatty acids supplementation and risk of atrial fibrillation. An updated meta-analysis of randomized controlled trials

2021 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Lombardi, Marco; Carbone, Salvatore; Del Buono, Marco Giuseppe; Chiabrando, Juan Guido; Vescovo, Giovanni Maria; Camilli, Massimiliano; Montone, Rocco Antonio; Vergallo, Rocco; Abbate, Antonio; Biondi-Zoccai, Giuseppe; Dixon, Dave L; Crea, Filippo

Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Battistoni, Allegra; Volpe, Massimo

Response to: Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan)

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Petramala, L.; Letizia, C.

P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Bianco, Matteo; Careggio, Alessandro; Destefanis, Paola; Luciano, Alessia; Perrelli, Maria Giulia; Quadri, Giorgio; Rossini, Roberta; Campo, Gianluca; Vizzari, Giampiero; D'Ascenzo, Fabrizio; Anselmino, Matteo; Biondi-Zoccai, Giuseppe; Ibáñez, Borja; Montagna, Laura; Varbella, Ferdinando; Cerrato, Enrico

Colchicine significantly increases the risk of non-cardiovascular death in patients with coronary artery disease

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Princi, Giuseppe; Crea, Filippo; Damario, Domenico

Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, M.; Andreotti, F.; D'Amario, D.; Vergallo, R.; Vescovo, G. M.; Giraldi, L.; Migliaro, S.; Ameri, P.; Porto, I.; Crea, F.

Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge

2019 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Borovac, J. A.; D'Amario, D.; Vergallo, R.; Porto, I.; Bisignani, A.; Galli, M.; Annibali, G.; Montone, R. A.; Leone, A. M.; Niccoli, G.; Crea, F.

Dual Therapy with DOACs significantly increases the risk of Stent Thrombosis compared to Triple Therapy

2019 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Andreotti, Felicita; D'Amario, Domenico; Vergallo, Rocco; Montone, Rocco A; Porto, Italo; Crea, Filippo

Non-steroidal anti-inflammatory drugs and incident atrial fibrillation

2015 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Proietti, Marco; Lip, Gregory Y. H.

Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2score

2015 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Proietti, Marco; Lip, Gregory Y. H.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma